Hospitals vs. specialty clinics: where should you get Rituximab?
Hospitals are the largest end‑user segment — they have the infusion suites, the emergency backup, and the multidisciplinary teams. But specialty clinics are the fastest‑growing. The rituximab market research study shows that specialty clinics are growing at over 7% CAGR, driven by the shift to outpatient cancer care and the rise of subcutaneous formulations. What's the...
0 Kommentare 0 Geteilt 49 Ansichten 0 Bewertungen